Hangzhou Baicheng Pharmaceutical Technology Co., Ltd. announces a continued suspension of trading due to significant uncertainties regarding a planned change of control involving major shareholders. The suspension will begin on May 27, 2026, and is expected to last no more than three trading days. The company will fulfill its disclosure obligations as the situation develops.
Summary generated by AI · Always verify with source document
Securities Code: 301096
Securities Abbreviation: Baicheng Pharmaceutical
Announcement Number: 2026-017
Hangzhou Baicheng Pharmaceutical Technology Co., Ltd. announces the continued suspension of trading due to the planned change of control. The company and all members of the board guarantee that the information disclosed is true, accurate, and complete, without false records, misleading statements, or significant omissions.
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.